1.25. Analysis.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 25 Number who suffered at least one adverse event of constipation before end of treatment at 6 months or later.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 25 Number who suffered at least one adverse event of constipation before end of treatment at 6 months or later.